{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:21:43Z","timestamp":1794547303000,"version":"4.9.1"},"reference-count":50,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["101055152"],"award-info":[{"award-number":["101055152"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lundbeckfonden","award":["R307-2018-2950"],"award-info":[{"award-number":["R307-2018-2950"]}],"id":[{"id":"https:\/\/ror.org\/03hz8wd80","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0069019"],"award-info":[{"award-number":["NNF21OC0069019"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>GPR183 is an oxysterol-sensing GPCR predominantly expressed in lymphoid organs and tissues. Activation of the receptor by oxysterol 7\u03b1,25-OHC leads to G\u03b1i protein-mediated signaling as well as \u03b2-arrestin2 recruitment. GPR183\/oxysterol signaling modulates localization of lymphoid cells; consequently, the receptor is associated with several inflammation-associated diseases and is an interesting potential drug target. Previously, we reported the discovery of moderately potent G protein-biased partial agonists for GPR183 from a virtual screening based on the antagonist NIBR189. Herein, we present the detailed structure\u2212activity investigations and optimizations, which led to the identification of full agonists for GPR183 with complete bias for G protein signaling and low nanomolar potency, including 63 (TUG-2604) with potency and efficacy similar to 7\u03b1,25-OHC. Notably, 63 was unable to induce migration of human dendritic cells but inhibited migration induced by 7\u03b1,25-OHC. This compound will be valuable for further explorations of the signaling-specific function and drug target potential of GPR183.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01079","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:02:22Z","timestamp":1791579742000},"page":"23346-23367","source":"Crossref","is-referenced-by-count":0,"title":["Development of Potent G Protein Pathway-Biased GPR183 Agonists"],"prefix":"10.1021","volume":"69","author":[{"given":"Kaustubh R.","family":"Bhuskute","sequence":"first","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Manandhar","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria M. S.","family":"Kj\u00e6r","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Blegdamsvej 3B , ,","place":["Copenhagen, Denmark, 2200"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Casartelli","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrud M.","family":"Hjort\u00f8","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Blegdamsvej 3B , ,","place":["Copenhagen, Denmark, 2200"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ioanna","family":"Koutsaki","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udhayabhaskar","family":"Sathyanarayanan","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Hjortkilde","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Turcio","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-3254","authenticated-orcid":true,"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Blegdamsvej 3B , ,","place":["Copenhagen, Denmark, 2200"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-1755","authenticated-orcid":true,"given":"Trond","family":"Ulven","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1243-7587","authenticated-orcid":true,"given":"Elisabeth","family":"Rexen Ulven","sequence":"additional","affiliation":[{"name":"University of Copenhagen , , Jagtvej 162 , ,","place":["Copenhagen, Denmark, 2100"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"2026102305080005600_cit1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1128\/jvi.67.4.2209-2220.1993","article-title":"Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors","volume":"67","author":"Birkenbach","year":"1993","journal-title":"J. Virol."},{"key":"2026102305080005600_cit2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/ni.2555","article-title":"The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells","volume":"14","author":"Gatto","year":"2013","journal-title":"Nat. Immunol."},{"key":"2026102305080005600_cit3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10226","article-title":"Oxysterols direct B-cell migration through EBI2","volume":"475","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"2026102305080005600_cit4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10280","article-title":"Oxysterols direct immune cell migration via EBI2","volume":"475","author":"Hannedouche","year":"2011","journal-title":"Nature"},{"key":"2026102305080005600_cit5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1124\/jpet.122.001283","article-title":"Activation of GPR183 by 7\u03b1,25-Dihydroxycholesterol Induces Behavioral Hypersensitivity through Mitogen-Activated Protein Kinase and Nuclear Factor-\u03baB","volume":"383","author":"Braden","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026102305080005600_cit6","doi-asserted-by":"publisher","first-page":"10671","DOI":"10.1039\/d2sc05962b","article-title":"Ligand entry pathways control the chemical space recognized by GPR183","volume":"14","author":"Kj\u00e6r","year":"2023","journal-title":"Chem. Sci."},{"key":"2026102305080005600_cit7","doi-asserted-by":"publisher","first-page":"13199","DOI":"10.1074\/jbc.M602245200","article-title":"Molecular pharmacological phenotyping of EBI2\ue5f8An orphan seven-transmembrane receptor with constitutive activity","volume":"281","author":"Rosenkilde","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2026102305080005600_cit8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2017.11.020","article-title":"Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation","volume":"48","author":"Emga\u030ard","year":"2018","journal-title":"Immunity"},{"key":"2026102305080005600_cit9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jlb.2vmr1217-510r","article-title":"EBI2 in splenic and local immune responses and in autoimmunity","volume":"104","author":"Barington","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"2026102305080005600_cit10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cells11030494","article-title":"GPR183 Is Dispensable for B1 Cell Accumulation and Function, but Affects B2 Cell Abundance, in the Omentum and Peritoneal Cavity","volume":"11","author":"Barington","year":"2022","journal-title":"Cells"},{"key":"2026102305080005600_cit11","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1111\/ejn.15359","article-title":"EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model","volume":"54","author":"Klejbor","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"2026102305080005600_cit12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/glia.22757","article-title":"EBI2 regulates intracellular signaling and migration in human astrocyte","volume":"63","author":"Rutkowska","year":"2015","journal-title":"Glia"},{"key":"2026102305080005600_cit13","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.3390\/ijms22094342","article-title":"EBI2 Is Temporarily Upregulated in MO3.13 Oligodendrocytes during Maturation and Regulates Remyelination in the Organotypic Cerebellar Slice Model","volume":"22","author":"Velasco-Estevez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026102305080005600_cit14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.immuni.2009.06.016","article-title":"Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses","volume":"31","author":"Gatto","year":"2009","journal-title":"Immunity"},{"key":"2026102305080005600_cit15","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.4049\/jimmunol.1101542","article-title":"EBI2 operates independently of but in cooperation with CXCR5 and CCR7 to direct B cell migration and organization in follicles and the germinal center","volume":"187","author":"Gatto","year":"2011","journal-title":"J. Immunol."},{"key":"2026102305080005600_cit16","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.4049\/jimmunol.1101262","article-title":"EBI2 guides serial movements of activated B cells and ligand activity is detectable in lymphoid and nonlymphoid tissues","volume":"187","author":"Kelly","year":"2011","journal-title":"J. Immunol."},{"key":"2026102305080005600_cit17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08226","article-title":"EBI2 mediates B cell segregation between the outer and centre follicle","volume":"460","author":"Pereira","year":"2009","journal-title":"Nature"},{"key":"2026102305080005600_cit18","doi-asserted-by":"publisher","first-page":"15926","DOI":"10.1021\/acs.jmedchem.3c01364","article-title":"Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis","volume":"66","author":"Xi","year":"2023","journal-title":"J. Med. Chem."},{"key":"2026102305080005600_cit19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1124\/jpet.120.000105","article-title":"GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic Pain","volume":"375","author":"Braden","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026102305080005600_cit20","doi-asserted-by":"publisher","first-page":"175872","DOI":"10.1016\/j.ejphar.2023.175872","article-title":"Activation of G-protein-coupled receptor 183 initiates inflammatory pain via macrophage CCL22 secretion","volume":"954","author":"Qi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"2026102305080005600_cit21","doi-asserted-by":"publisher","first-page":"2201306","DOI":"10.1183\/13993003.01306-2022","article-title":"GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection","volume":"61","author":"Foo","year":"2023","journal-title":"Eur. Respir. J."},{"key":"2026102305080005600_cit22","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1111\/bph.15395","article-title":"A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease","volume":"178","author":"Ruiz","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"2026102305080005600_cit23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41385-019-0140-x","article-title":"The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis","volume":"12","author":"Wyss","year":"2019","journal-title":"Mucosal Immunol."},{"key":"2026102305080005600_cit24","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1021\/acs.jmedchem.3c01905","article-title":"Discovery of a Highly Potent Oxysterol Receptor GPR183 Antagonist Bearing the Benzo[d]thiazole Structural Motif for the Treatment of Inflammatory Bowel Disease (IBD)","volume":"67","author":"Zeng","year":"2024","journal-title":"J. Med. Chem."},{"key":"2026102305080005600_cit25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.fob.2013.02.003","article-title":"Small molecule antagonism of oxysterol-induced Epstein-Barr virus induced gene 2 (EBI2) activation","volume":"3","author":"Benned-Jensen","year":"2013","journal-title":"FEBS Open Bio"},{"key":"2026102305080005600_cit26","doi-asserted-by":"publisher","first-page":"601534","DOI":"10.3389\/fimmu.2020.601534","article-title":"GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity","volume":"11","author":"Bartlett","year":"2020","journal-title":"Front. Immunol."},{"key":"2026102305080005600_cit27","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1093\/infdis\/jiac102","article-title":"A Blunted GPR183\/Oxysterol Axis During Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung During Mycobacterium tuberculosis Infection","volume":"225","author":"Ngo","year":"2022","journal-title":"J. Infect. Dis."},{"key":"2026102305080005600_cit28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12974-017-1025-0","article-title":"EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination","volume":"14","author":"Rutkowska","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"2026102305080005600_cit29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.celrep.2017.01.020","article-title":"EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and Promotes Early CNS Migration of Encephalitogenic CD4 T Cells","volume":"18","author":"Wanke","year":"2017","journal-title":"Cell Rep."},{"key":"2026102305080005600_cit30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207108","article-title":"The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"2026102305080005600_cit31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/08916934.2022.2103119","article-title":"Abnormal lower expression of GPR183 in peripheral blood T and B cell subsets of systemic lupus erythematosus patients","volume":"55","author":"Zhao","year":"2022","journal-title":"Autoimmunity"},{"key":"2026102305080005600_cit32","doi-asserted-by":"publisher","first-page":"29292","DOI":"10.1074\/jbc.M110.196345","article-title":"Ligand modulation of the Epstein-Barr virus-induced seven-transmembrane receptor EBI2","volume":"286","author":"Benned-Jensen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2026102305080005600_cit33","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1021\/jm4019355","article-title":"Identification and characterization of small molecule modulators of the Epstein-Barr virus-induced gene 2 (EBI2) receptor","volume":"57","author":"Gessier","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026102305080005600_cit34","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/bph.13801","article-title":"Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2","volume":"174","author":"Daugvilaite","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"2026102305080005600_cit35","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/cmdc.202100301","article-title":"Discovery of GPR183 Agonists Based on an Antagonist Scaffold","volume":"16","author":"Kjaer","year":"2021","journal-title":"ChemMedChem"},{"key":"2026102305080005600_cit36","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abl4283","article-title":"Migration mediated by the oxysterol receptor GPR183 depends on arrestin coupling but not receptor internalization","volume":"16","author":"Kj\u00e6r","year":"2023","journal-title":"Sci. Signal."},{"key":"2026102305080005600_cit37","doi-asserted-by":"publisher","first-page":"35470","DOI":"10.1074\/jbc.m112.387894","article-title":"Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183)","volume":"287","author":"Benned-Jensen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2026102305080005600_cit38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Drug Discovery"},{"key":"2026102305080005600_cit39","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"2026102305080005600_cit40","doi-asserted-by":"publisher","first-page":"10010","DOI":"10.1038\/s41598-018-28263-7","article-title":"Structure-Activity Investigations and Optimisations of Non-metabolite Agonists for the Succinate Receptor 1","volume":"8","author":"Ulven","year":"2018","journal-title":"Sci. Rep."},{"key":"2026102305080005600_cit41","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"2026102305080005600_cit42","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"2026102305080005600_cit43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J. Neurochem."},{"key":"2026102305080005600_cit44","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1111\/bph.15811","article-title":"Community guidelines for GPCR ligand bias: IUPHAR review 32","volume":"179","author":"Kolb","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"2026102305080005600_cit45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fendo.2015.00167","article-title":"A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate","volume":"6","author":"Levoye","year":"2015","journal-title":"Front. Endocrinol."},{"key":"2026102305080005600_cit46","doi-asserted-by":"publisher","first-page":"8340","DOI":"10.3390\/ijms22158340","article-title":"Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer","volume":"22","author":"Brandum","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026102305080005600_cit47","doi-asserted-by":"publisher","first-page":"108786","DOI":"10.1016\/j.pharmthera.2024.108786","article-title":"Biased signaling in GPCRs: Structural insights and implications for drug development","volume":"266","author":"Ma","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"2026102305080005600_cit48","doi-asserted-by":"publisher","first-page":"2.14.11","DOI":"10.1002\/0471141755.ph0214s70","article-title":"Using Bioluminescence Resonance Energy Transfer (BRET) to Characterize Agonist-Induced Arrestin Recruitment to Modified and Unmodified G Protein-Coupled Receptors","volume":"70","author":"Donthamsetti","year":"2015","journal-title":"Curr. Protoc. Pharmacol."},{"key":"2026102305080005600_cit49","doi-asserted-by":"publisher","first-page":"10576","DOI":"10.1074\/jbc.m609695200","article-title":"Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate\/G13 pathway","volume":"282","author":"Jiang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2026102305080005600_cit50","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3389\/fimmu.2016.00568","article-title":"Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines","volume":"7","author":"Hjort\u00f8","year":"2016","journal-title":"Front. Immunol."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01079","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23346\/68809506\/jm6c01079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23346\/68809506\/jm6c01079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:22:16Z","timestamp":1794543736000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/23346\/5448413\/Development-of-Potent-G-Protein-Pathway-Biased"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":50,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,9]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01079","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01079.s004","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]}}}